MIMEDX GROUP, INC. (MDXG) › Cash & EquivalentsMIMEDX GROUP, INC. (MDXG) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $2.65M2010: $1.34M2011: $4.11M2012: $6.75M2013: $44.08M2014: $46.58M2015: $26.30M2016: $30.32M2017: $27.48M2018: $45.12M2019: $69.07M2020: $95.81M2021: $87.08M2022: $65.95M2023: $82.00M2024: $104.42M2025: $166.12M$166.12M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$166.12M+59.1%2024$104.42M+27.3%2023$82.00M+24.3%2022$65.95M-24.3%2021$87.08M-9.1%2020$95.81M+38.7%2019$69.07M+53.1%2018$45.12M+64.2%2017$27.48M-9.4%2016$30.32M+15.3%2015$26.30M-43.5%2014$46.58M+5.7%2013$44.08M+552.6%2012$6.75M+64.2%2011$4.11M+206.7%2010$1.34M-49.5%2009$2.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share